Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib - Yeo_2017_PLoS.One_12_e0182115 |
| Author(s) : Yeo A , Li L , Warren L , Aponte J , Fraser D , King K , Johansson K , Barnes A , Macphee C , Davies R , Chissoe S , Tarka E , O'Donoghue ML , White HD , Wallentin L , Waterworth D |
| Ref : PLoS ONE , 12 :e0182115 , 2017 |
| Abstract : Yeo_2017_PLoS.One_12_e0182115 |
| ESTHER : Yeo_2017_PLoS.One_12_e0182115 |
| PubMedSearch : Yeo_2017_PLoS.One_12_e0182115 |
| PubMedID: 28753643 |
| Gene_locus related to this paper: human-PLA2G7 |
| Title : Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations - Song_2012_Pharmacogenomics.J_12_425 |
| Author(s) : Song K , Nelson MR , Aponte J , Manas ES , Bacanu SA , Yuan X , Kong X , Cardon L , Mooser VE , Whittaker JC , Waterworth DM |
| Ref : Pharmacogenomics J , 12 :425 , 2012 |
| Abstract : Song_2012_Pharmacogenomics.J_12_425 |
| ESTHER : Song_2012_Pharmacogenomics.J_12_425 |
| PubMedSearch : Song_2012_Pharmacogenomics.J_12_425 |
| PubMedID: 21606947 |
| Gene_locus related to this paper: human-PLA2G7 |